<\/p>\n
Ezedoc<\/strong> indeholder ezetimibe<\/strong> (10 mg), en kolesterolabsorptionsh\u00e6mmer<\/strong> der blokerer NPC1L1-transport\u00f8ren i tyndtarmen. Det er go-to add-on therapy when a statin alone doesn\u2019t get LDL to target<\/strong>. On its own, ezetimibe lowers LDL-C by about 17\u201322%. Added to a statin, it produces an additional ~20\u201325% LDL reduction, totaling a 55\u201360% fall \u2014 equivalent to doubling the statin dose without the dose-related muscle or liver side effects. The unders\u00f8gelsen (18.144 patienter efter ACS) beviste, at tilf\u00f8jelse af ezetimibe til simvastatin yderligere reducerer kardiovaskul\u00e6re h\u00e6ndelser. Dosis: 10 mg \u00e9n gang dagligt, n\u00e5r som helst, med eller uden mad. Generelt meget godt tolereret \u2014 mild mave-tarm-ubehag, lejlighedsvis myalgi, sj\u00e6lden transaminaseforh\u00f8jelse. Undg\u00e5 ved sv\u00e6r leversvigt.<\/strong> trial (18,144 patients post-ACS) proved that adding ezetimibe to simvastatin further reduces cardiovascular events. Dose: 10\u00a0mg once daily, any time, with or without food. Generally very well-tolerated \u2014 mild GI upset, occasional myalgia, rare transaminase elevation. Avoid in severe hepatic impairment.<\/p>\n<\/div>\n \ud83d\udce6 Hver ordre er d\u00e6kket af vores Reshipment Assurance Policy<\/strong><\/a> \u2014 hvis din pakke ikke ankommer inden for 20 hverdage, sender vi en erstatning.<\/p>\n Vores generiske l\u00e6gemidler kommer fra WHO-GMP-certificerede producenter og sendes verdensrundt i diskret, neutral emballage \u2014 ingen l\u00e6gemiddelnavn p\u00e5 pakkens ydre. Kortbetalinger h\u00e5ndteres af en reguleret processor (kontoudtogsbeskrivelser inkluderer en reguleret betalingsprocessor \u2014 aldrig \u201cMedsBase\u201d eller noget l\u00e6gemiddelnavn). Crypto og SEPA bankoverf\u00f8rsel accepteres ogs\u00e5. Hver ordre er d\u00e6kket af vores Reshipment Assurance Policy.<\/p>\n Ezedoc er et oralt lipids\u00e6nkende l\u00e6gemiddel, der indeholder ezetimibe<\/strong> (10 mg), fremstillet af WHO-GMP-certificeret producent. Leveres i pakninger med 30, 60, 90 eller 180 tabletter. Ezetimibe er det f\u00f8rste og eneste l\u00e6gemiddel i kolesterolabsorptionsh\u00e6mmer<\/strong> klasse. Originalpr\u00e6parat: Zetia \/ Ezetrol<\/strong> (Merck, 2002).<\/p>\n Ezetimibe is a mainstay of second-line lipid management \u2014 the first choice when you need more LDL reduction than a tolerated statin dose provides, or when a patient cannot tolerate higher statin doses. It is also the most common partner in fixed-dose combinations (simvastatin\/ezetimibe = Inegy\/Vytorin; rosuvastatin\/ezetimibe = various).<\/p>\n Ezetimibe is weak as a monotherapy (~17% LDL reduction) compared to a statin (~30\u201360%); it is most powerful as an add-on.<\/p>\n Ezetimib h\u00e6mmer selektivt Niemann-Pick C1-Like 1 (NPC1L1)-transport\u00f8ren<\/strong> p\u00e5 enterocytter i den proximale tyndtarm. NPC1L1 er ansvarlig for optagelsen af kost- og galdecholesterol fra tarmlumen ind i enterocyten.<\/p>\n N\u00e5r NPC1L1 er blokeret:<\/p>\n Fordi ezetimib og statiner virker p\u00e5 komplement\u00e6re pathways<\/strong> (absorption vs synthesis), their effects are additive. Statins reduce LDL synthesis; ezetimibe reduces LDL absorption\/input. Together they drop LDL more than either can alone, without adding to each other\u2019s side-effect profile.<\/p>\n Resultatdata: IMPROVE-IT-studien<\/strong> (2015) viste, at tilf\u00f8jelse af ezetimib til simvastatin hos patienter efter akut koronart syndrom reducerede det sammensatte kardiovaskul\u00e6re slutpunkt med 6,4% (NNT 50 over 7 \u00e5r), hvilket bekr\u00e6fter, at LDL-s\u00e6nkningen f\u00f8rer til faktisk reduktion i h\u00e6ndelser.<\/p>\n Standarddosis:<\/strong> 10\u00a0mg once daily at any time of day, with or without food.<\/p>\n Ezetimib er et af de bedst tolererede lipid-s\u00e6nkende l\u00e6gemidler. Bivirkninger er t\u00e6t p\u00e5 placeborater i kliniske fors\u00f8g.<\/p>\n Almindelige (< 5%):<\/strong><\/p>\n Mindre almindelige:<\/strong><\/p>\n Store Ezedoc below 25\u00b0C in a dry place, in the original blister. Keep out of reach of children.<\/p>\n Usually no. As monotherapy, ezetimibe lowers LDL by only ~17% \u2014 much less than a statin (30\u201360%). It is appropriate as monotherapy only for patients who cannot tolerate any statin at any dose. For most people, the best lipid-lowering strategy is statin first, ezetimibe added if LDL is still above target.<\/p>\n Doubling a statin dose typically adds ~6% LDL reduction (the statin \u201crule of 6\u201d). Adding ezetimibe adds ~20\u201325% LDL reduction. Adding ezetimibe is 3\u20134\u00d7 more effective<\/strong> i stedet for at fordoble statindosisen, og uden den dosisrelaterede stigning i muskelsymptomer. Derfor foretr\u00e6kker moderne retningslinjer en kombination af statin + ezetimib frem for at skrue statindosisen op til maksimum.<\/p>\n Yes \u2014 the IMPROVE-IT trial (18,144 post-ACS patients) showed adding ezetimibe to simvastatin reduced the composite endpoint of CV death, MI, unstable angina, revascularisation, or stroke by 6.4% over 7 years. This is the landmark evidence that LDL reduction beyond statins alone still translates into real cardiovascular benefit.<\/p>\n Any time of day is fine. Unlike simvastatin (evening preferred), ezetimibe timing is not dose-dependent \u2014 pick a time you will remember consistently. Many patients take it at the same time as their statin.<\/p>\n Sj\u00e6ldent. Ezetimib-monoterapi viser bivirkninger p\u00e5 muskelniveau svarende til placebo. N\u00e5r det kombineres med et statin, \u00f8ger det ikke meningsfuldt statinrelaterede muskelsymptomer sammenlignet med statin alene.<\/p>\n Du kan bestille Ezedoc (10 mg) fra MedsBase i pakker med 30, 60, 90 eller 180 tabletter. Vi sender worldwide med diskret emballage og \u00e6gte WHO-GMP-certificeret fabrikantbeholdning.<\/p>\n Ezedoc leveres gennem en WHO-GMP-certificeret fabrikant med fuld COA-dokumentation. Vi sender worldwide i simpel, diskret emballage, og hver ordre er d\u00e6kket af vores Reshipment Assurance Policy<\/a>. Your statement descriptor when paying by card shows the regulated payment processor (a regulated card-payment processor), never \u201cMedsBase\u201d or any medication name.<\/p>\n <\/p>\n Andre produkter inden for Kroniske tilstande<\/strong> som kunder ogs\u00e5 ser:<\/p>\n \u2705 S\u00e6nker kolesterolniveauet Ezedoc<\/strong> indeholder Ezetimibe<\/strong>.<\/p>","protected":false},"featured_media":56973,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[3141,3223,3953],"product_tag":[4210,4211],"class_list":{"0":"post-56972","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-category-overview","7":"product_cat-chronic-conditions","8":"product_cat-high-cholesterol-treatments","9":"product_tag-ezedoc","10":"product_tag-ezetimibe","12":"first","13":"instock","14":"shipping-taxable","15":"purchasable","16":"product-type-variable","17":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/da\/wp-json\/wp\/v2\/product\/56972","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/da\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/da\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/da\/wp-json\/wp\/v2\/comments?post=56972"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/da\/wp-json\/wp\/v2\/media\/56973"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/da\/wp-json\/wp\/v2\/media?parent=56972"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/da\/wp-json\/wp\/v2\/product_brand?post=56972"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/da\/wp-json\/wp\/v2\/product_cat?post=56972"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/da\/wp-json\/wp\/v2\/product_tag?post=56972"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}Hvorfor bestille fra MedsBase<\/h3>\n
Ezedoc er en oral lipid-s\u00e6nkende medicin, der indeholder<\/h2>\n
Hvad Bruges Ezedoc Til?<\/h2>\n
\n
Hvordan virker Ezedoc?<\/h2>\n
\n
Dosering og administration<\/h2>\n
\n
Bivirkninger<\/h2>\n
\n
\n
L\u00e6gemiddelinteraktioner<\/h2>\n
\n
Hvem b\u00f8r ikke tage Ezedoc?<\/h2>\n
\n
Opbevaring<\/h2>\n
Ofte stillede sp\u00f8rgsm\u00e5l<\/h2>\n
Kan jeg tage Ezedoc i stedet for et statin?<\/h3>\n
Hvordan sammenlignes Ezedoc med at fordoble min statindosis?<\/h3>\n
Reducerer Ezedoc hjerteanfald og slagtilf\u00e6lde?<\/h3>\n
Hvorn\u00e5r skal jeg tage Ezedoc?<\/h3>\n
For\u00e5rsager Ezedoc muskelsmerter som statin?<\/h3>\n
Hvor kan jeg k\u00f8be Ezedoc online?<\/h3>\n
Relaterede kolesteroll\u00e6gemidler<\/h2>\n
\n
Hvorfor bestille fra MedsBase<\/h3>\n
Relaterede alternativer<\/h3>\n
\n
\n\u2705 Reducerer risikoen for hjertekarsygdom
\n\u2705 Forebygger \u00e5reforkalkning
\n\u2705 Ordineret af l\u00e6ger
\n\u2705 Oral medicinmulighed<\/p>\n